Add BrightSurf on Google Email

Understanding the immune response to a persistent pathogen

A team of researchers from the University of Pennsylvania School of Veterinary Medicine has made a groundbreaking discovery about the immune system's response to the latent stage of Toxoplasma gondii. The study found that certain T cells can target neurons containing cysts, promoting parasite control. However, this process also poses a...

SourceUniversity of Pennsylvania·JournalNature Microbiology·TypeExperimental study·DateMar 28, 2025

New research brings hope for improved outcomes and survival rates for patients facing a pancreatic cancer diagnosis

Researchers at Trinity College Dublin have discovered a biomarker panel that can accurately identify patients at risk of developing pancreatic cancer, offering new hope for early detection and improved treatment. The study uses a combination of blood and fluid analysis to distinguish between low- and high-risk patients.

SourceTrinity College Dublin·JournalScientific Reports·TypeExperimental study·DateFeb 18, 2025

New findings in JNCCN illustrate pathway for screening high-risk individuals for pancreatic cancer in PRECEDE study

The PRECEDE study found that nearly 80% of participants in the highest-risk cohort completed baseline imaging, highlighting the feasibility of improving early detection and prevention for pancreatic cancer. Researchers recommend sorting individuals into three groups based on family history and genetic mutations to tailor surveillance.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateApr 16, 2024

NTU Singapore scientists grow ‘mini kidneys,’ revealing new insights into metabolic defects and potential therapy for polycystic kidney disease

Researchers at NTU Singapore successfully grew 'mini kidneys' in the lab, grafted them into live mice, and found a potential treatment for polycystic kidney disease by boosting autophagy. The study suggests that minoxidil could be used to reduce cysts in the novel mouse model.

SourceNanyang Technological University·JournalCell Stem Cell·TypeExperimental study·DateApr 8, 2024

Novel technique distinguishes between types of oral bone lesion based on MRI scan image texture

Researchers used MRI scans and texture analysis to differentiate between two types of benign oral bone lesions, ameloblastomas and odontogenic keratocysts. The study found that certain pixel and voxel organizational parameters in the MRI images were statistically significant, enabling more accurate diagnosis and treatment planning.

Women with benign breast disease face higher risk of breast cancer in the long term

A large observational study found that women diagnosed with benign breast disease through screening are at a higher risk of developing breast cancer in the long term. The risk persisted for at least two decades and was found to be significantly higher among women with benign breast disease compared to those without.

SourceEuropean Organisation for Research and Treatment of Cancer·JournalInternational Journal of Environmental Research and Public Health·TypeObservational study·DateNov 17, 2022

Pitt-developed genetic test for pancreatic cancer outperforms current guidelines

A new genetic test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, improving the accuracy of diagnoses compared to current guidelines. The test distinguishes between different types of cysts with higher accuracy than traditional forms of surveillance and current pancreatic cyst guidelines.

SourceUniversity of Pittsburgh·JournalGastroenterology·TypeObservational study·DateOct 5, 2022

UCSF-led research team reveals mechanisms at work in progression of pancreatic cysts to pancreatic cancer

A UCSF-led team reveals that tumor immune microenvironments play a crucial role in the progression of pancreatic cysts to pancreatic cancer. The study suggests that therapies targeting regulatory T cells and myeloid-derived suppressor cells could inhibit malignant progression and treat high-risk disease.

SourceUniversity of California San Francisco Medical Center·JournalThe Lancet·TypeExperimental study·DateAug 31, 2022

Solving a puzzle

Tuberous sclerosis complex (TSC) affects millions worldwide, causing cysts and benign tumors to form in the kidney, leading to kidney failure. Researchers led by Dr. Manoocher Soleimani found that changes in cells lining the collecting ducts are responsible for cyst formation, offering new avenues for potential treatments.

SourceUniversity of New Mexico Health Sciences Center·JournalProceedings of the National Academy of Sciences·DateFeb 3, 2021

Strike three

A team of researchers has discovered a previously unrecognized mechanism that accelerates cystogenesis in polycystic kidney disease (PKD), leading to rapid cyst growth and kidney failure. The study suggests that increasing water intake and avoiding certain foods may slow the progression of ADPKD.

SourceUniversity of California - Santa Barbara·JournalJournal of Clinical Investigation·DateAug 26, 2019

Machine learning platform guides pancreatic cyst management in patients

Researchers created a comprehensive test using machine learning algorithms to better guide patient management for pancreatic cysts, a precursor of pancreatic cancer. The test, called CompCyst, outperformed the current standard-of-care in an international study, avoiding surgery in 60% of patients who underwent unnecessary removal.

SourceAmerican Association for the Advancement of Science (AAAS)·JournalScience Translational Medicine·DateJul 17, 2019

New drug targets for a rare kidney and liver disease

Researchers have identified new potential drug targets for a rare kidney and liver disease by studying the molecular mechanisms underlying the disease. The study found that a protein complex, FPC, plays a key role in the development of cysts, fibrosis, and hypertension associated with ARPKD.

SourceOsaka University·JournalScientific Reports·DateAug 23, 2017

How to stop the nasty lurking toxoplasmosis parasite? Target its 'stomach,' study suggests

Researchers at U-M Medical School discovered that a molecule called cathepsin protease L is crucial to the parasite's ability to survive the cyst phase and cause disease. Interfering with this protein can stop the parasite, offering new hope for treatments. The study suggests that targeting the 'stomach' of the parasite may be key to p...

SourceMichigan Medicine - University of Michigan·JournalNature Microbiology·DateJun 19, 2017